Literature DB >> 12507785

CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium.

Kakuri M Omari1, Katerina Dorovini-Zis.   

Abstract

Recent evidence suggests that interactions between CD40 on antigen presenting cells (APC) and CD40L on T cells generate signals that result in the activation of APC. In this study, the expression and function of CD40 was investigated in primary cultures of human brain microvessel endothelial cells (HBMEC). Results revealed constitutive expression of CD40 on untreated HBMEC. Stimulation with TNF-alpha, IFN-gamma, LPS or combination of TNF-alpha and IFN-gamma significantly upregulated CD40. The majority of CD40 molecules were localized on the apical surface of EC. Incubation of HBMEC with soluble CD40L resulted in increased expression of the adhesion molecules E-selectin, VCAM-1 and ICAM-1. Consequently, the adhesion of both resting and anti-CD3 activated CD4+ T lymphocytes to CD40L treated HBMEC was significantly increased compared to unstimulated EC. The expression of CD40 by cerebral endothelium, and endothelial cell activation following binding of CD40 to its ligand, CD40L, suggest a potential mechanism by which activated CD40L expressing T cells could enhance adhesion and migration of inflammatory cells across the blood-brain barrier (BBB) to sites of inflammation in the human central nervous system (CNS).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507785     DOI: 10.1016/s0165-5728(02)00423-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  25 in total

Review 1.  Sepsis-associated delirium.

Authors:  Marion Ebersoldt; Tarek Sharshar; Djillali Annane
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

2.  Endothelial microparticles interact with and support the proliferation of T cells.

Authors:  Julie Wheway; Sharissa L Latham; Valery Combes; Georges E R Grau
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

Review 3.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis.

Authors:  Jagannadha R Avasarala; Sastry S Konduru
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Infection of the endothelium by members of the order Rickettsiales.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

6.  Peripheral T-lymphocyte and natural killer cell population imbalance is associated with septic encephalopathy in patients with severe sepsis.

Authors:  Cheng-Xiang Lu; Ting Qiu; Hua-Sheng Tong; Zhi-Feng Liu; Lei Su; Biao Cheng
Journal:  Exp Ther Med       Date:  2016-01-15       Impact factor: 2.447

7.  Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.

Authors:  Jenny A Garcia; Paula A Pino; Makiko Mizutani; Sandra M Cardona; Israel F Charo; Richard M Ransohoff; Thomas G Forsthuber; Astrid E Cardona
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

8.  CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins.

Authors:  Jennifer Van Grol; Luis Muniz-Feliciano; Jose-Andres C Portillo; Vera L Bonilha; Carlos S Subauste
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

9.  CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.

Authors:  Karen Y Stokes; Leshanna Calahan; Candiss M Hamric; Janice M Russell; D Neil Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-12-26       Impact factor: 4.733

10.  CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis.

Authors:  Elizabeth Sitati; Erin E McCandless; Robyn S Klein; Michael S Diamond
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.